Hims & Hers Health will acquire Zava, expanding the company's services to Ireland, France and Germany and growing its active ...

Hims & Hers Health (NYSE:HIMS) announced on Tuesday an acquisition of the European digital health platform, ZAVA, as part of ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced a significant step in its ...

Hims & Hers Health agreed to acquire Zava, a digital health platform in Europe. The telehealth-consultation platform said its acquisition will expand its footprint into the United Kingdom and ...

Hims & Hers Health sees some volatility with revenue growth, 38% subscriber increase, and promising telehealth market demand.

US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava ...

Hims & Hers Health (NYSE: HIMS), a telehealth platform, experienced an 8% increase in its stock on Friday, May 30th, ...

The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.

Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Investors are buying Hims & Hers Health ( HIMS 10.09%) stock hand over fist after the mail-order drugs company reported an earnings miss but a sales beat last night. But they're selling off shares of ...

Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...